Survival rate and predictors of mortality among TB/HIV co-infected adult patients: retrospective cohort study
- PMID: 36319734
- PMCID: PMC9626487
- DOI: 10.1038/s41598-022-23316-4
Survival rate and predictors of mortality among TB/HIV co-infected adult patients: retrospective cohort study
Abstract
Nowadays, Tuberculosis remains the major cause of HIV-associated mortality, which accounts for 1 out of every 5 HIV-related mortality worldwide. This study aimed to determine the survival rate and predictors of mortality among TB/HIV co-infected patients. An institution-based retrospective cohort study was undertaken on adult TB/HIV co-infected individuals between 1st February 2014 and 30th January 2022 at Mettu Karl Referral Hospital. A Cox regression model was used to identify predictors of survival time to death among TB/HIV co-infected patients. This study comprised 402 TB and HIV co-infected adult patients. Among these, 84 (20.9%) died, and 318 (79.1%) were censored. The study subjects have been followed up for 6920 person-months with an overall median survival time of 17.6 months. The overall incidence rate was 12.1 per 1000 person months [95% CI: 9.77-14.98]. The results of a multivariable Cox regression analysis showed that being at an older age, urban residence, WHO clinical stage II & IV, CD4 count of ≥ 200 cells/mm3, bedridden functional status, using INH, and using CPT were associated with the survival time of TB and HIV co-infected patients at a significance level of alpha = 0.05. This retrospective study found that high mortality of TB/HIV co-infected patients occurred in the earlier months of treatment initiation. Close monitoring of patients with low CD4, who do not utilize CPT, who are in advanced WHO stages, and who have poor functional levels can help them improve their health and live longer.
© 2022. The Author(s).
Conflict of interest statement
The authors declare no competing interests.
Figures



Similar articles
-
Modeling Survival Time to Death Among TB and HIV Co-infected Adult Patients: an Institution-Based Retrospective Cohort Study.J Racial Ethn Health Disparities. 2023 Aug;10(4):1616-1628. doi: 10.1007/s40615-022-01348-w. Epub 2022 Jun 13. J Racial Ethn Health Disparities. 2023. PMID: 35697902
-
Early Mortality during Initial Treatment of Tuberculosis in Patients Co-Infected with HIV at the Yaoundé Central Hospital, Cameroon: An 8-Year Retrospective Cohort Study (2006-2013).PLoS One. 2015 Jul 27;10(7):e0132394. doi: 10.1371/journal.pone.0132394. eCollection 2015. PLoS One. 2015. PMID: 26214516 Free PMC article.
-
Survival and predictors of mortality among children co-infected with tuberculosis and human immunodeficiency virus at University of Gondar Comprehensive Specialized Hospital, Northwest Ethiopia. A retrospective follow-up study.PLoS One. 2018 May 22;13(5):e0197145. doi: 10.1371/journal.pone.0197145. eCollection 2018. PLoS One. 2018. PMID: 29787596 Free PMC article.
-
Improving survival with tuberculosis & HIV treatment integration: A mini-review.Indian J Med Res. 2019 Aug;150(2):131-138. doi: 10.4103/ijmr.IJMR_660_19. Indian J Med Res. 2019. PMID: 31670268 Free PMC article. Review.
-
Tuberculosis associated mortality in a prospective cohort in Sub Saharan Africa: Association with HIV and antiretroviral therapy.Int J Infect Dis. 2017 Mar;56:39-44. doi: 10.1016/j.ijid.2017.01.023. Epub 2017 Feb 1. Int J Infect Dis. 2017. PMID: 28161460 Review.
Cited by
-
Incidence rate of mortality and its predictors among tuberculosis and human immunodeficiency virus coinfected patients on antiretroviral therapy in Ethiopia: systematic review and meta-analysis.Front Med (Lausanne). 2024 Apr 19;11:1333525. doi: 10.3389/fmed.2024.1333525. eCollection 2024. Front Med (Lausanne). 2024. PMID: 38707189 Free PMC article.
-
Correlates of HIV-TB co-infection and mental health of adults living in countries across sub-Saharan Africa: systematic review and meta-analysis protocol.BMJ Open. 2025 Jun 13;15(6):e095280. doi: 10.1136/bmjopen-2024-095280. BMJ Open. 2025. PMID: 40514230 Free PMC article.
-
Predictors of Longitudinal Viral Load count and Survival Time to Death Among Adult TB/HIV Coinfected Patients Treated at Two Selected Amhara Region Comprehensive Specialized Hospitals, Ethiopia.Health Sci Rep. 2025 Jun 17;8(6):e70867. doi: 10.1002/hsr2.70867. eCollection 2025 Jun. Health Sci Rep. 2025. PMID: 40535517 Free PMC article.
-
Predictors of quality of life of TB/HIV co-infected patients in the Northern region of Ghana.BMC Infect Dis. 2024 Apr 12;24(1):396. doi: 10.1186/s12879-024-09247-7. BMC Infect Dis. 2024. PMID: 38609839 Free PMC article.
-
Tuberculosis-associated mortality and risk factors for HIV-infected population in Ethiopia: a systematic review and meta-analysis.Front Public Health. 2024 Jul 22;12:1386113. doi: 10.3389/fpubh.2024.1386113. eCollection 2024. Front Public Health. 2024. PMID: 39104893 Free PMC article.
References
-
- Tola A, Mishore KM, Ayele Y, Mekuria AN, Legese N. Treatment outcome of tuberculosis and associated factors among TB-HIV Co-infected patients at public hospitals of Harar town, Eastern Ethiopia. A five-year retrospective study. BMC Public Health. 2019;19:1–12. doi: 10.1186/s12889-019-7980-x. - DOI - PMC - PubMed
-
- Gezae KE, Abebe HT, Gebretsadik LG, Gebremeskel AK. Predictors of time to death among TB/HIV co-infected adults on ART at two governmental hospitals in Mekelle, Ethiopia, 2009–2016: A retrospective cohort study. Ann. Infect. Dis. Epidemiol. 2020;2020(5):1049.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Research Materials